Streamliners may have solved a few of its key marketing and technology problems by deciding to integrate with rapidly growing AI behemoth Heidi.
Streamliners has some of the most detailed and important clinical pathways IP in the country but until now it’s been locked up by legacy technology and a group with great intent but not enough capital to market their great IP far and wide.
That problem might have been solved today by a management decision to integrate their information and data, and functionality as far as it can be, with rapidly growing industry AI behemoth Heidi.
The most immediate advantage of the partnership will be visibility and distribution.
On the back of Heidi’s rapidly growing reach to doctors, and their increasing trust profile the partnership will very likely enhance the support available to frontline clinicians within the clinical consultation workflow by linking Heidi Health’s AI-powered clinician assistance with HealthPathways’ localised clinical guidance.
Today Heidi Health announced its big expansion into decision support and trusted evidenced based information sharing through its launch of Heidi Evidence and acquisition of evidence led AI framework company Automedica.
Heidi’s IP and reputation sit very neatly into this strategy in Australia and New Zealand.
“Clinicians use both HealthPathways and Heidi extensively in their daily practice, from GP clinics to hospital wards, and in allied health settings,” says Mike Weiss, Streamliners CEO.
“We’re excited to be partnering with Heidi Health as a global leader in AI integration. Linking the clinical evidence-based benefits of HealthPathways with the Heidi user experience is a natural fit for us.
“As health and care systems around the world continue to face extreme pressures, we’re innovating proactively to meet the demand for increased efficiency and more joined-up systems through smarter workflow integration.”
Related
The partnership will help to accelerate evidence and policy into clinical practice, says Dr Kieran Holland, Streamliners’ Clinical Director of Research.
“AI scribes and evidence products are rapidly becoming part of routine clinical workflows, and clinicians want those tools to reflect local pathways and agreed models of care,” he says.
“Safely and securely integrating HealthPathways with AI with appropriate safeguards will ensure patients get the best local care, save time for clinicians, and deliver system level benefits through improved patient flow. We’re pleased to be working with a well-established AI partner like Heidi as together we enable new, more efficient models of care which put the patient at the centre.”
Where local HealthPathways guidance is available, clinicians using Heidi will in future be able to benefit from it as part of an assistive, clinician-led documentation and workflow experience.
According to Mr Weiss, Streamliners and Heidi Health will work closely together to ensure the appropriate safety and security measures are in place.
“Development will be informed by feedback from clinicians and local stakeholders across the global HealthPathways network”, he says.